Cognitive impairment burden in older and younger adults across the kidney transplant care continuum

Background: Younger kidney transplant (KT) candidates and recipients may have cognitive impairment due to chronic diseases and reliance on dialysis. Methods: To quantify cognitive impairment burden by age across the KT care continuum, we leveraged a two-center cohort study of 3854 KT candidates at evaluation, 1114 recipients at admission, and 405 recipients at 1-year post-KT with measured global cognitive performance (3MS) or executive function (Trail Making Test). We also estimated burden of severe cognitive impairment that affects functional dependence (activities of daily living [ADL] < 6 or instrumental activities of daily living [IADL] < 8). Results: Among KT candidates, global cognitive impairment (18–34 years: 11.1%; 35–49 years: 14.0%; 50–64 years: 19.5%; ≥65 years: 22.0%) and severe cognitive impairment burden (18–34 years: 1.1%; 35–49 years: 3.0%; 50–64 years: 6.2%; ≥65 years: 7.7%) increased linearly with age. Among KT recipients at admission, global cognitive impairment (18–34 years: 9.1%; 35–49 years: 6.1%; 50–64 years: 9.3%; ≥65 years: 15.7%) and severe cognitive impairment burden (18–34 years: 1.4%; 35–49 years: 1.4%; 50–64 years: 2.2%; ≥65 years: 4.6%) was lower. Despite lowest burden of cognitive impairment among KT recipients at 1-year post-KT across all ages (18–34 years: 1.7%; 35–49 years: 3.4%; 50–64 years: 4.3%; ≥65 years: 6.5%), many still exhibited severe cognitive impairment (18–34 years:.0%; 35–49 years: 1.9%; 50–64 years: 2.4%; ≥65 years: 3.5%). Conclusion: Findings were consistent for executive function impairment. While cognitive impairment increases with age, younger KT candidates have a high burden comparable to community-dwelling older adults, with some potentially suffering from severe forms. Transplant centers should consider routinely screening patients during clinical care encounters regardless of age.